LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 16.29 | 84.90 | 1258 | 766 | 1.6405 | 1.3374 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 17.99 | 84.90 | 18 | 898 | 0.0200 | -0.3659 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 17.99 | 84.90 | 1346 | 898 | 1.4973 | 1.2517 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 17.99 | 84.90 | 13 | 898 | 0.0145 | -0.4237 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 17.99 | 84.90 | 1375 | 898 | 1.5295 | 1.2659 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 19.69 | 84.90 | 244 | 1239 | 0.1969 | 0.3138 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 19.69 | 84.90 | 1483 | 1239 | 1.1965 | 1.0950 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 19.69 | 84.90 | 18 | 1239 | 0.0145 | -0.3304 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 19.69 | 84.90 | 1539 | 1239 | 1.2417 | 1.1151 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 21.40 | 84.90 | 273 | 1454 | 0.1877 | 0.3297 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 21.40 | 84.90 | 1607 | 1454 | 1.1047 | 1.0492 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 21.40 | 84.90 | 39 | 1454 | 0.0268 | -0.1729 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 21.40 | 84.90 | 1659 | 1454 | 1.1405 | 1.0652 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 23.10 | 84.90 | 332 | 1616 | 0.2054 | 0.3783 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 23.10 | 84.90 | 1809 | 1616 | 1.1193 | 1.0537 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 23.10 | 84.90 | 50 | 1616 | 0.0309 | -0.1171 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 23.10 | 84.90 | 1769 | 1616 | 1.0945 | 1.0430 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.81 | 84.90 | 469 | 1769 | 0.2651 | 0.4771 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.81 | 84.90 | 1931 | 1769 | 1.0913 | 1.0403 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.81 | 84.90 | 63 | 1769 | 0.0356 | -0.0658 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.81 | 84.90 | 1922 | 1769 | 1.0862 | 1.0381 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 26.51 | 84.90 | 551 | 1923 | 0.2865 | 0.5151 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 26.51 | 84.90 | 2038 | 1923 | 1.0597 | 1.0259 | MN20160318_Q02 | H11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 26.51 | 84.90 | 70 | 1923 | 0.0364 | -0.0420 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 26.51 | 84.90 | 2097 | 1923 | 1.0904 | 1.0388 | MN20160318_Q02 | K13 |